<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1"><url><loc>https://insights.citeline.com/pink-sheet/compliance/manufacturing/us-fda-seeking-to-expand-global-footprint-again-with-japan-vietnam-foreign-offices-D3QFFZSGAVBNLOT6QU5D5WT4DI/</loc><lastmod>2026-04-09T23:04:25.45Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/WZz7pEHsQ1E0TdJqvejw42QL4yY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/5TV4EU3IYNGDXOHUX5VXGRQY4A.jpg</image:loc><image:caption><![CDATA[New FDA foreign offices are planned for Tokyo and Hanoi.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/market-access/health-technology-assessment/englands-hta-body-reverses-rejection-for-serivers-voranigo-PJBEGVWBPNCWTGYMBZC6UHL2ZM/</loc><lastmod>2026-04-09T23:04:16.833Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/wtVLpGe_08xNqcyW-_W0rU2kbsc=/cloudfront-us-east-1.images.arcpublishing.com/norstella/BDM7H5PEKZCT3B72OW6HTGKREE.jpg</image:loc><image:caption><![CDATA[Voranigo is to be made available to patients via the National Health Service in England]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/agency-leadership/us-fda/us-fda-will-formalize-single-trial-policy-later-this-year-makary-says-TW6TK6F4ZFERPPSXTVWURKYTSA/</loc><lastmod>2026-04-09T23:03:44.614Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/Xwo-YP1JyzC3x1K58pf1Ks3cqqs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HCM4JDT6ZBC2PJUIMO3DXQUWH4.jpg</image:loc><image:caption><![CDATA[FDA Commissioner Martin Makary, here speaking during a recent expert panel, wants the agency to have more power to stop clinical trials early, if warranted.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/market-access/pricing-debate/us-tariffs-bring-turning-point-for-global-trade-of-pharmaceuticals-774RZM4XE5AZNNGURMVHXZPPN4/</loc><lastmod>2026-04-09T23:03:26.194Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/5jDUK1S7736ll9RLt8ZLCTpPm_A=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WWSK42FZVJDALHISMGT5OCTJNA.jpg</image:loc><image:caption><![CDATA[A 15% tariff rate on European drug exports to the US "is the best of a bad situation."]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/market-access/pricing-debate/abbvie-340b-patient-definition-lawsuit-highlights-challenges-with-manufacturer-audits-UAQLL3PR6BBQ7LAEDLLD7VC4BM/</loc><lastmod>2026-04-09T23:03:09.644Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/LBVytPB1-eCuloDsvcZLv5h5868=/cloudfront-us-east-1.images.arcpublishing.com/norstella/4AA2ZWGZFRFLXHMWFLDCRLV3IE.jpg</image:loc><image:caption><![CDATA[Manufacturers increasing pressure on 340B providers.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/hbw-insight/wellness/policy-and-regulation/white-house-requests-fda-food-programs-spending-boost-but-lower-overall-fy-2027-budget-RFBCZPITMJA3LE5LSTMMLZV4T4/</loc><lastmod>2026-04-09T22:13:01.458Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/OjQhp9vqJDcbmGxRXo1QDrzppj8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/MFJNHJWRCNE2PD4XSS73FHUSW4.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/hbw-insight/beauty/policy-and-regulation/childrens-beauty-boom-signals-caution-for-brands-in-europe-OQQ67ZE44VEFXDFAVIQJ2XTH2I/</loc><lastmod>2026-04-09T22:04:19.023Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/Qyey_fPsOnvPlDwGu7Qo1POebDo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/RZKTBYFR5NA2PHABOOACD3EIHQ.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/scrip/therapeutic-category/anti-infective/another-one-bites-the-dust-iterum-shuts-shop-as-antibiotic-woes-drag-on-CIZTPUSFFVBN3GEWB3576MVPQA/</loc><lastmod>2026-04-09T21:55:45.436Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/I11mG5VC9GSYmd_f5a2tej9gFS0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/M4NGDPTNBNC25EQMIXTODHATSE.jpg</image:loc><image:caption><![CDATA[Antibiotics are medications that kill or inhibit the growth of bacteria.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/scrip/leadership/executives-on-the-move/executives-on-the-move-orion-gets-senior-executive-from-johnson-johnson-7TBBGUZOIZBYHKK5PSLCEILKBI/</loc><lastmod>2026-04-09T21:54:48.492Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/scrip/business/strategy/assertio-agrees-to-buyout-by-garda-therapeutics-7VUT3QSE45HTVB6QI2KYYLOCLM/</loc><lastmod>2026-04-09T21:54:42.658Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/pz2-p7sBd1BnB-qkW6Z6ju4EQ7E=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KXO7AEXD3FCZ7G6SR3S5IQWQ4Q.jpg</image:loc><image:caption><![CDATA[Assertio agreed to an acquisition by privately held Garda Therapeutics.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/scrip/business/deals/roche-and-c4-expand-alliance-into-degrader-antibody-conjugate-work-JO5FLJPGYJCZPLEITAT5TLPYO4/</loc><lastmod>2026-04-09T21:54:08.882Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/S33uev2p8EatfV9QUT9ATFIhplY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IUICLMRRL5FCDHAL26CO2QYMTM.jpg</image:loc><image:caption><![CDATA[Roche and C4 expand their collaboration into DAC therapies for cancer]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-alternative-funding-agreements-abound-from-small-to-large-biopharma-J7NUFIYRTRF4HFUCBIUHW3FEK4/</loc><lastmod>2026-04-09T21:53:05.392Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/QP0XsTOKIkbEiMw2sxA1vTD-XIs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/UUPCCTOSUNI7ZKUU3DO7RIZNHI.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/medtech-insight/leadership/execs-on-the-move-march-30april-3-2026-HKMXVDPACNABNLU64SHASUQOUI/</loc><lastmod>2026-04-09T20:41:36.59Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/h4fVGgwOIyO4RzeYcyFoc_E91Qo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QSTAM7SGMJOYTGEBU2RZSDKLYA.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/medtech-insight/business/deals/deals-shaping-the-medtech-and-diagnostics-industries-march-2026-FCRIL7E22VDS5IDXLOEFU7YNEE/</loc><lastmod>2026-04-09T20:35:50.065Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/6igbtvkFnjpZVZUA8b4QFedP1xM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3AZTY7EIT5OW7BKPGOOG62P6TQ.png</image:loc></image:image></url><url><loc>https://insights.citeline.com/medtech-insight/digital-technologies/fda-challenges-innovators-to-help-reduce-hospital-readmissions-by-advancing-at-home-care-7RH7X46ATFHDVJMV2EYPMIVMOM/</loc><lastmod>2026-04-09T20:33:15.265Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/jwR2HQWHXmAiDq3dS8jInVy2HZs=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HFKOQZQF4FHGBHGT3VHQ4QC5YE.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/medtech-insight/business/strategy/noctrixs-nidra-breaks-through-wearable-noise-to-win-coverage-for-restless-leg-syndrome-treatment-LOJ75OFRLBBT7O67DGUG42KY6Y/</loc><lastmod>2026-04-09T19:15:25.496Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/31DE_mkd07kmcpCSryGpnYHlySk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/OSCSXP57AVDRTKCWB463XRSMCA.jpg</image:loc><image:caption><![CDATA[Noctrix Medical's Nidra system is the first wearable treatment for RLS.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/medtech-insight/cortecs-ceo-says-fda-breakthrough-marks-shift-to-therapeutic-bci-for-stroke-7K7TAE4U5FEVHPRSCYGOHYA4QI/</loc><lastmod>2026-04-09T17:41:48.01Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/6NEoK2aTK5mjq2yq7caozSDqUrE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/HXWKWFUSZ5GPVKUI5DUTJ7CNLU.jpg</image:loc><image:caption><![CDATA[Germany-based CorTec GmbH has received US FDA beakthrough device designation for its brain-computer interface (BCI) system designed to restore motor function in stroke patients.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/medtech-insight/policy-and-regulation/eu/ai-act-updates-risk-consumer-harm-from-medical-devices-eu-civil-society-orgs-say-6H65TMNP5JDIVC3KIP5ZJ2B7VM/</loc><lastmod>2026-04-09T15:32:30.813Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/oSwxh0ZyUh_yErhLj-KZsskkzkY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SQRI3RAXMRFFJPJT7SONUER66Y.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/hbw-insight/health/innovationandip/opella-sees-role-for-evidencebased-selfcare-in-early-masld-care-LA6NDZSKTRBQRJCDSXIFGO2NWU/</loc><lastmod>2026-04-09T14:44:51.388Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/dEhLRPAln9vKz3a8gc0Dad5IK9w=/cloudfront-us-east-1.images.arcpublishing.com/norstella/RYSJB5TV65CRTO3EAFGXFYTIVU.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/hbw-insight/wellness/business/strategy/people-on-the-move-appointments-at-barentz-iherb-lonza-G7Y62DUX6NHFNGIBZC24JEA5PY/</loc><lastmod>2026-04-09T14:16:32.175Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/XRh-5oJ5WoSHVjEL4B3D8Dpf02c=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DKTPK5V2NNPOVFXHWRKOPKEK4M.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/medtech-insight/policy-and-regulation/us-fda/fda-and-industry-reach-agreement-in-principle-on-mdufa-vi-framework-SBLT2OS7TFEWZCIV6YCAEZ4QBY/</loc><lastmod>2026-04-09T13:38:55.284Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/fIkWSqCoAb2wsKIJMlZTPRRb4_0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/IFBWPNSKEBA7BCOW2OUIQY5N6Y.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/medtech-insight/device-area/diagnostics/singapores-asian-population-cohort-dataset-to-move-forward-with-seers-proteograph-platform-I2SSZMVHYRGU5JHXJYBKKNZPUM/</loc><lastmod>2026-04-09T13:04:29.408Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/Qgh4zErgtQdeWz1BfK6rcGnYamY=/cloudfront-us-east-1.images.arcpublishing.com/norstella/JRNRYW5ZLZCWXHZRADM66MB6MY.jpg</image:loc><image:caption><![CDATA[The Proteograph suite delivers high-throughput analysis of proteins directly from biological samples such as blood. Picture Courtesy: Seer]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/generics-bulletin/leadership/interviews/eggs-solve-all-of-those-problems-how-neion-bio-is-seeking-to-shake-up-biosimilar-manufacturing-I5LCU2765BAHHLQ56ES4ALIZ3M/</loc><lastmod>2026-04-09T12:30:38.918Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/QUq-mZm4D6h2shUfisIU_uTrJiU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/GJYYXPFL4VDRHCWGPSIX4D3DXY.png</image:loc><image:caption><![CDATA[(L-R) Demetrios Kellari, Sam Levin and Ming Li]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/generics-bulletin/leadership/interviews/generics-remain-critical-foundation-for-arcera-SDWNPKMDPZAWFLJ5J6RQ6FJWVE/</loc><lastmod>2026-04-09T10:54:41.254Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/bmCMGNpLEPNBNlkwzw3F1lw8FKI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WLCQWORAXRANPITIT35EPUFVAE.jpg</image:loc><image:caption><![CDATA[Isabel Afonso, CEO of Arcera]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/generics-bulletin/policy-and-regulation/regulation/us-fda/fda-budget-offers-update-on-domestic-incentives-for-para-iv-filings-4Z6QFSCTJBH2PNAGXZSSO2DFFA/</loc><lastmod>2026-04-09T10:54:17.293Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/EEOVLukhMeTauFzz1hCUSa5Xk_g=/cloudfront-us-east-1.images.arcpublishing.com/norstella/W427QS6RKVCALJLCLGHKNEDJIM.jpg</image:loc><image:caption><![CDATA[The FDA is proposing incentivizing domestic production with early Paragraph IV filings]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/generics-bulletin/products/biosimilars/biocon-launches-held-back-denosumab-biosimilars-in-the-us-RUJD5RVCLVHU5LEU6ORW7X3ES4/</loc><lastmod>2026-04-09T10:47:31.156Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/nwv8ldP-D3Af2hluvy607Slr5u0=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2FQVD5SDDFGN5JTZS3BFJC5Y44.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/generics-bulletin/legalandip/msn-deal-ends-trulance-dispute-signals-launch-pathway-OM7BTJLNEJETVLGTEGMYTBJZ6I/</loc><lastmod>2026-04-09T10:31:11.326Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/pGebhKh8RQT7HA0ALMYEdPSoXw8=/cloudfront-us-east-1.images.arcpublishing.com/norstella/DJCVW72DVNCHBK4RU4GLGZQ3NE.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/in-vivo/deal-making/deals-shaping-the-industry-march-2026-HLLV3BBV2RAWRPL5JW4EIIDNOM/</loc><lastmod>2026-04-09T08:15:06.595Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/6igbtvkFnjpZVZUA8b4QFedP1xM=/cloudfront-us-east-1.images.arcpublishing.com/norstella/3AZTY7EIT5OW7BKPGOOG62P6TQ.png</image:loc></image:image></url><url><loc>https://insights.citeline.com/in-vivo/podcasts/podcast-how-israel-is-positioning-itself-as-a-global-innovation-hub-BRZAIQENRRCXFLK255DQOZUVN4/</loc><lastmod>2026-04-09T07:29:43.089Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/ZRS16ILQ0j4uuhBNksV741SfUWI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/I775OILYCVCTFNEIV7IFDNKQQI.png</image:loc></image:image></url><url><loc>https://insights.citeline.com/medtech-insight/device-area/cardiology/no-new-hardware-required-bds-hemosphere-stream-to-bring-continuous-bp-monitoring-to-any-bedside-QONU3XSYWRGF7GVU6YGS2T43KE/</loc><lastmod>2026-04-09T07:17:56.663Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/hTBMQXiwv1b3e4a6BtTBpNQWjZ4=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XT4J3MHU5FBJPIBJLOCAN4YXLM.jpg</image:loc><image:caption><![CDATA[The HemoSphere Stream Module itself is designed specifically to deliver continuous blood pressure readings through the bedside monitor and does not provide the additional hemodynamic parameters. Picture Courtesy: Becton Dickinson]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/hbw-insight/beauty/innovationandip/new-products/paris-in-cosmetics-global-2026-ingredient-preview-VQQ2WPSWVVFA3IMDWK5MZV2K4E/</loc><lastmod>2026-04-09T02:39:02.467Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/T4bXpr_0d-V8nttRJADuNlfBZKI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2HCQAD27DNG7FC5IVNFAYKL5RQ.jpg</image:loc><image:caption><![CDATA[Givaudan uses GenAI-powered tools to demonstrate PrimalHyal NeuroYouth anti-aging skin care]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/scrip/r-and-d/clinical-trials/brinsupris-resounding-hs-failure-wont-hold-insmed-back-XPJYNQRSSZA4FCFWI5PC6OVOCE/</loc><lastmod>2026-04-09T01:45:46.444Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/SeBiJjKe2C5E_wzpVd1C-Vx3oho=/cloudfront-us-east-1.images.arcpublishing.com/norstella/44EOBPVAQFEDBGKFTXH4YPGXHY.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/scrip/business/financing/finance-watch/finance-watch-three-vc-mega-rounds-already-in-april-for-syneron-sidewinder-stipple-QPWUYAHRBNDRPJA776SHM66KSE/</loc><lastmod>2026-04-09T01:45:33.639Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/cInTrHhf4lm96TCzMQLN0bLTTRI=/cloudfront-us-east-1.images.arcpublishing.com/norstella/SDNUC6JU3VLANCGYXXII3MD4RM.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/scrip/business/strategy/shah-capital-blasts-novavax-strategy-in-new-letter-to-board-A6DIVMGGQFDHVFBDLLQJWCPK5Y/</loc><lastmod>2026-04-09T01:44:28.355Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/fybuHQwa7p4dPEuyv7Aw7Vi9Hvo=/cloudfront-us-east-1.images.arcpublishing.com/norstella/XH3U2YIY2NFEVAJ2PKQRKHVNRM.jpg</image:loc><image:caption><![CDATA[Shah Capital criticized Novavax's strategy in its latest letter to the company's board.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/scrip/business/deals/shionogi-gets-119m-fetroja-purchase-commitment-from-barda-R7BNEWQDP5FXFCSJHET6MN55ME/</loc><lastmod>2026-04-09T01:43:53.305Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/nn3HSNpC_adKSVDk3KrpaOCOA0k=/cloudfront-us-east-1.images.arcpublishing.com/norstella/KKMVLN6V2FMYPKQCVGZOLLD6RU.jpg</image:loc><image:caption><![CDATA[BARDA commits to multi-year purchase of Shionogi's Petroja]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/scrip/leadership/outgoing-phrma-ceo-ubl-fought-shaped-policies-and-politics-around-price-controls-BO2T3USA7VDCJARR4W7LQ5BPGE/</loc><lastmod>2026-04-09T01:42:43.266Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/7CKxVP6vi10qf1aZWdfTOo0VtJU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QLDGOUQEPBAXTGZ6HCHKGKYYAI.jpg</image:loc><image:caption><![CDATA[PhRMA CEO Steve Ubl speaks during the recent PhRMA Forum.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/regulatory-trackers/global-pharma-guidance-update/global-pharma-guidance-tracker-march-2026-EVHY43JLLJBJ5H45ZPLJTZXAX4/</loc><lastmod>2026-04-09T01:22:57.149Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/pyXNgDhSsN63aHmz5GtethgJs6Y=/cloudfront-us-east-1.images.arcpublishing.com/norstella/J47YR4CKUVM3VELDJJRV4RSQ4A.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/drug-safety/judge-stays-louisiana-mifepristone-suit-orders-us-fda-safety-review-update-within-six-months-AHWUZFY325CPPL24OP2M2HBR2M/</loc><lastmod>2026-04-09T01:22:21.146Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/W0T3ETP33opY0BhlMOwsPMZzLok=/cloudfront-us-east-1.images.arcpublishing.com/norstella/ZDPGATZM4FB2LH5ZB7BFJ6KS6M.jpg</image:loc><image:caption><![CDATA[A federal judge halted litigation filed by Louisiana over mifepristone prescribing.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/compliance/inadequate-pfas-restriction-derogations-still-threaten-eu-drug-access-and-manufacturing-KL2RPCUZ2FG6ND6BL7CAULQWTE/</loc><lastmod>2026-04-09T01:21:58.734Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/AzCBuar_tXf1HKlQaRWqB41_LtU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/6PLPP2QKKRBRHKO6W3CCTIFRQA.jpg</image:loc><image:caption><![CDATA[Opinions on PFAS restrictions from the European Chemicals Agency are "alarming," says EFPIA. Agency]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/r-and-d/breaking-phrma-ceo-steve-ubl-leaving-later-this-year-2FNX2D5LE5GC3J2HARTZPHZDB4/</loc><lastmod>2026-04-09T01:21:29.92Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/7CKxVP6vi10qf1aZWdfTOo0VtJU=/cloudfront-us-east-1.images.arcpublishing.com/norstella/QLDGOUQEPBAXTGZ6HCHKGKYYAI.jpg</image:loc><image:caption><![CDATA[PhRMA CEO Steve Ubl speaks during the recent PhRMA Forum.]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/pink-sheet/rare-diseases/a-regulatory-pathway-of-one-us-fdas-wellcovorin-approval-would-be-hard-to-scale-BHEAMFMG5BDJHJY5K6Z5OJF22A/</loc><lastmod>2026-04-09T01:20:49.445Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/_tP9BVj-2r4NGF94jXyU4NaFwkE=/cloudfront-us-east-1.images.arcpublishing.com/norstella/WDX7E2WYURFKDHTBBO3HTTADOA.jpg</image:loc><image:caption><![CDATA[The US FDA's approval of Wellcovorin for FOLR1-CFTD was an impressive feat, but can it be repeated?]]></image:caption></image:image></url><url><loc>https://insights.citeline.com/hbw-insight/health/rx-to-otc-switch/researchers-make-case-to-expand-medication-abortion-access-but-note-otc-approval-unlikely-OK7K4JUOL5FWZDNL2Y5IPU63UQ/</loc><lastmod>2026-04-09T01:03:33.928Z</lastmod><changefreq>always</changefreq><priority>0.5</priority><image:image><image:loc>https://insights.citeline.com/resizer/NCT7UkKWBsLWaq1VpXRz7eDopMk=/cloudfront-us-east-1.images.arcpublishing.com/norstella/2QAHN6YIIFCZDJ2IJ6AGWOUISU.jpg</image:loc></image:image></url><url><loc>https://insights.citeline.com/companies/resonac-holdings-corporation</loc><lastmod>2026-04-09T00:14:14.731Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/eske-srl</loc><lastmod>2026-04-09T00:14:12.459Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/vitropep-sas</loc><lastmod>2026-04-09T00:14:10.58Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/shanghai-yuansong-biotechnology-co-ltd</loc><lastmod>2026-04-09T00:14:08.539Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/national-institute-for-health-and-care-research-nihr</loc><lastmod>2026-04-09T00:14:01.403Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/lin-gang-laboratory</loc><lastmod>2026-04-09T00:13:59.439Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/vitalis</loc><lastmod>2026-04-09T00:13:57.398Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/university-college-london-hospitals-nhs-foundation-trust-uclh</loc><lastmod>2026-04-09T00:13:55.355Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/wuhan-shinegen-biotechnology</loc><lastmod>2026-04-09T00:13:53.387Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/allevion-medical</loc><lastmod>2026-04-09T00:13:46.606Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/guangzhou-manjing-biomedicine-technology-co-ltd</loc><lastmod>2026-04-09T00:13:44.218Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/alderley-analytical</loc><lastmod>2026-04-09T00:13:42.074Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/exactice-medical-inc</loc><lastmod>2026-04-09T00:13:40.119Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/shanghai-institutes-for-biological-sciences</loc><lastmod>2026-04-09T00:13:38.08Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/eth-zurich</loc><lastmod>2026-04-09T00:13:32.315Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/hangzhou-diagens-biotechnology-co-ltd</loc><lastmod>2026-04-09T00:13:30.151Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/shanghai-bensheng-pharmaceutical</loc><lastmod>2026-04-09T00:13:28.193Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/guangdong-longchuangji-pharmaceutical-co-ltd</loc><lastmod>2026-04-09T00:13:26.132Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/nihr-oxford-biomedical-research-centre</loc><lastmod>2026-04-09T00:13:24.063Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/sharp</loc><lastmod>2026-04-09T00:13:21.179Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/minimed-inc</loc><lastmod>2026-04-09T00:13:17.038Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/primo-biotechnology-co-ltd</loc><lastmod>2026-04-09T00:13:08.98Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/shanghai-zhigen-pharmaceutical-technology-co-ltd</loc><lastmod>2026-04-09T00:13:05.198Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/centivax</loc><lastmod>2026-04-09T00:13:00.871Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/sentinel-biotherapeutics</loc><lastmod>2026-04-09T00:12:56.882Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/organoid-sciences</loc><lastmod>2026-04-09T00:12:52.96Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/maipl-therapeutics-inc</loc><lastmod>2026-04-09T00:12:48.836Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/amc-science</loc><lastmod>2026-04-09T00:12:45.12Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/guangdong-hongshanhu-pharmaceutical</loc><lastmod>2026-04-09T00:12:40.528Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/beijing-cosci-med-tech</loc><lastmod>2026-04-09T00:12:36.758Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/guangzhou-runer-ophthalmic</loc><lastmod>2026-04-09T00:12:32.633Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/closed-loop-medicine</loc><lastmod>2026-04-09T00:12:28.503Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/renascience-inc</loc><lastmod>2026-04-09T00:12:20.431Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/nterica-bio-inc</loc><lastmod>2026-04-09T00:12:16.502Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/iolyx-therapeutics-inc</loc><lastmod>2026-04-09T00:12:12.437Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/otsuka-pharmaceutical</loc><lastmod>2026-04-09T00:12:08.32Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/quotient-therapeutics-inc</loc><lastmod>2026-04-09T00:12:04.557Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/optus-pharmaceutical-co-ltd</loc><lastmod>2026-04-09T00:12:00.141Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/rigerna-therapeutics</loc><lastmod>2026-04-09T00:11:56.058Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/mallia-therapeutics-gmbh</loc><lastmod>2026-04-09T00:11:52.293Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/opsidio-llc</loc><lastmod>2026-04-09T00:11:40.07Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/starmab-biologics-shanghaicoltd</loc><lastmod>2026-04-09T00:11:35.945Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/ncc-bio</loc><lastmod>2026-04-09T00:11:32.157Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/gat-therapeutics</loc><lastmod>2026-04-09T00:11:27.984Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/thpharm-corp</loc><lastmod>2026-04-09T00:11:24.128Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/stemmedical-as</loc><lastmod>2026-04-09T00:11:20.005Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/tuhura-biosciences-inc</loc><lastmod>2026-04-09T00:11:15.937Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/transcend-therapeutics</loc><lastmod>2026-04-09T00:11:11.89Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/piramal-pharma-ltd</loc><lastmod>2026-04-09T00:11:07.839Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/ausper-biopharma-co-ltd</loc><lastmod>2026-04-09T00:11:03.942Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/pentixapharm-holding-ag</loc><lastmod>2026-04-09T00:10:59.869Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/youthbio-therapeutics-inc</loc><lastmod>2026-04-09T00:10:55.774Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/prokidney-lp</loc><lastmod>2026-04-09T00:10:51.618Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/sk-bioscience-co-ltd</loc><lastmod>2026-04-09T00:10:47.739Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/jiangsu-recbio-technology-co-ltd</loc><lastmod>2026-04-09T00:10:43.742Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/k36-therapeutics-inc</loc><lastmod>2026-04-09T00:10:39.744Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/keymed-biosciences-inc</loc><lastmod>2026-04-09T00:10:36.014Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/pharmcadd</loc><lastmod>2026-04-09T00:10:27.642Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/hitachi-ltd</loc><lastmod>2026-04-09T00:10:23.57Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/mineralys-therapeutics-inc</loc><lastmod>2026-04-09T00:10:19.491Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/microport-cardioflow-medtech-corp</loc><lastmod>2026-04-09T00:10:15.647Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/wuhan-yzy-biopharma-co-ltd</loc><lastmod>2026-04-09T00:10:11.713Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/talis-biomedical-corp</loc><lastmod>2026-04-09T00:10:07.301Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/fukushima-sic-applied-engineering-inc</loc><lastmod>2026-04-09T00:10:03.477Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/corxel-pharmaceuticals-limited</loc><lastmod>2026-04-09T00:09:59.252Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/reig-jofre</loc><lastmod>2026-04-09T00:09:55.241Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/remegen-ltd</loc><lastmod>2026-04-09T00:09:51.173Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/natera-inc</loc><lastmod>2026-04-09T00:09:47.151Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/pegbio-co-ltd</loc><lastmod>2026-04-09T00:09:43.087Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/jsr-life-sciences-corporation</loc><lastmod>2026-04-09T00:09:31.066Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/nyrada-inc</loc><lastmod>2026-04-09T00:09:29.034Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/race-oncology-ltd</loc><lastmod>2026-04-09T00:09:27.008Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/aurisco-pharmaceutical-co-ltd</loc><lastmod>2026-04-09T00:09:25.147Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/tr-biofab-co-ltd</loc><lastmod>2026-04-09T00:09:22.999Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/nibec-co-ltd</loc><lastmod>2026-04-09T00:09:20.965Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/treace-medical-concepts-inc</loc><lastmod>2026-04-09T00:09:16.995Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/butterfly-network-inc</loc><lastmod>2026-04-09T00:09:12.863Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/rapid-micro-biosystems-inc</loc><lastmod>2026-04-09T00:09:08.822Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/united-laboratories-inc</loc><lastmod>2026-04-09T00:09:05.106Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/osang-healthcare-co-ltd</loc><lastmod>2026-04-09T00:09:00.799Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/zeon-corporation</loc><lastmod>2026-04-09T00:08:56.991Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/xilio-therapeutics-inc</loc><lastmod>2026-04-09T00:08:52.837Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/biora-therapeutics-inc</loc><lastmod>2026-04-09T00:08:48.879Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/theracyte-inc</loc><lastmod>2026-04-09T00:08:45.304Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/lotus-pharmaceutical-co-ltd</loc><lastmod>2026-04-09T00:08:39.937Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/novmetapharma-co-ltd</loc><lastmod>2026-04-09T00:08:33.552Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/yale-school-of-medicine</loc><lastmod>2026-04-09T00:08:27.62Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/jiangsu-kanion-pharmaceutical-co-ltd</loc><lastmod>2026-04-09T00:08:21.524Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/sight-sciences-inc</loc><lastmod>2026-04-09T00:08:15.431Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/opus-genetics-inc</loc><lastmod>2026-04-09T00:08:09.448Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/olix-pharmaceuticals-inc</loc><lastmod>2026-04-09T00:08:03.483Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/tonghua-dongbao-pharmaceutical-co-ltd</loc><lastmod>2026-04-09T00:07:57.579Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/suzhou-ribo-life-science-co-ltd</loc><lastmod>2026-04-09T00:07:51.376Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/kymera-therapeutics-inc</loc><lastmod>2026-04-09T00:07:45.278Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/profound-medical-corporation</loc><lastmod>2026-04-09T00:07:39.394Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/quince-therapeutics-inc</loc><lastmod>2026-04-09T00:07:33.388Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/sedana-medical-ab</loc><lastmod>2026-04-09T00:07:27.462Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/verrica-pharmaceuticals-inc</loc><lastmod>2026-04-09T00:07:21.195Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/trisalus-life-sciences</loc><lastmod>2026-04-09T00:07:15.262Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/shandong-weigao-group-medical-polymer-company-limited</loc><lastmod>2026-04-09T00:07:09.262Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/endospan</loc><lastmod>2026-04-09T00:07:03.6Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/sera-prognostics-inc</loc><lastmod>2026-04-09T00:06:57.198Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/orchestra-biomed-holdings-inc</loc><lastmod>2026-04-09T00:06:51.362Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/boryung-pharmaceutical-co-ltd</loc><lastmod>2026-04-09T00:06:45.1Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/quanterix-corporation</loc><lastmod>2026-04-09T00:06:39.095Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/wockhardt-limited</loc><lastmod>2026-04-09T00:06:32.934Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/pharmaresearch</loc><lastmod>2026-04-09T00:06:27.075Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/inventiva-sa</loc><lastmod>2026-04-09T00:06:20.906Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/cour-pharmaceuticals</loc><lastmod>2026-04-09T00:06:14.878Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/saniona-ab</loc><lastmod>2026-04-09T00:06:08.999Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/mereo-biopharma-group-plc</loc><lastmod>2026-04-09T00:06:02.946Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/nexstim-plc</loc><lastmod>2026-04-09T00:05:56.842Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/ovid-therapeutics-inc</loc><lastmod>2026-04-09T00:05:50.777Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/palisade-bio-inc</loc><lastmod>2026-04-09T00:05:44.757Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/sutro-biopharma-inc</loc><lastmod>2026-04-09T00:05:38.933Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/rani-therapeutics-holdings-inc</loc><lastmod>2026-04-09T00:05:32.677Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/ose-immunotherapeutics</loc><lastmod>2026-04-09T00:05:26.702Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/seres-therapeutics-inc</loc><lastmod>2026-04-09T00:05:14.736Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/whitehawk-therapeutics-inc</loc><lastmod>2026-04-09T00:05:08.402Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/kazia-therapeutics-limited</loc><lastmod>2026-04-09T00:05:02.417Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/oncolytics-biotech-inc</loc><lastmod>2026-04-09T00:04:56.436Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/rezolute-inc</loc><lastmod>2026-04-09T00:04:50.456Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/intellipharmaceutics-international-inc</loc><lastmod>2026-04-09T00:04:44.224Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/sensorion-sa</loc><lastmod>2026-04-09T00:04:38.07Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/galera-therapeutics-inc</loc><lastmod>2026-04-09T00:04:32.31Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/nordmark-arzneimittel-gmbh-co-kg</loc><lastmod>2026-04-09T00:04:26.084Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/transgene-sa</loc><lastmod>2026-04-09T00:04:20.055Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/iovance-biotherapeutics-inc</loc><lastmod>2026-04-09T00:04:14.26Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/novabay-pharmaceuticals-inc</loc><lastmod>2026-04-09T00:04:05.246Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/minerva-neurosciences-inc</loc><lastmod>2026-04-09T00:03:52.96Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/pepgen-inc</loc><lastmod>2026-04-09T00:03:29Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/santhera-pharmaceuticals</loc><lastmod>2026-04-09T00:03:05.021Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/merit-medical-systems-inc</loc><lastmod>2026-04-09T00:02:52.882Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/orexo-ab</loc><lastmod>2026-04-09T00:02:40.927Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/perspective-therapeutics-inc</loc><lastmod>2026-04-09T00:02:28.632Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/artivion-inc</loc><lastmod>2026-04-09T00:02:16.765Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/cipher-pharmaceuticals-inc</loc><lastmod>2026-04-09T00:02:05.345Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/cook-group-inc</loc><lastmod>2026-04-09T00:01:52.846Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/merck-kgaa</loc><lastmod>2026-04-09T00:01:41.803Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url><url><loc>https://insights.citeline.com/companies/sangamo-therapeutics-inc</loc><lastmod>2026-04-09T00:01:16.791Z</lastmod><changefreq>always</changefreq><priority>0.5</priority></url></urlset>